Speaker Information
Keynote Address
Penelope Brock, MD, PhD, FRCPCH
University College London
2020 Bellucci Prize Winner
"From symptoms to solutions: an example of international collaboration"
University College London
2020 Bellucci Prize Winner
"From symptoms to solutions: an example of international collaboration"
About Penelope Brock, MD, PhD, FRCPCH
Penelope Brock, better known as Peppy, went to school in England but studied medicine in French at Louvain and paediatrics in Dutch at Leuven University in Belgium. She did a fellowship at Great Ormond Street Hospital (GOSH) in London from 1986-88 when she became a founding member of the European Liver Tumour group SIOPEL, joined the European Neuroblastoma group SIOPEN and started her PhD on cisplatin toxicity in infants and children.
She returned to Leuven to set up the paediatric haematology/oncology unit there and became Professor of Paediatric Haematology and Oncology in 1994. In 1999 she was invited back to be consultant oncologist at GOSH where her focus became solid tumours, particularly hepatoblastoma and neuroblastoma.
She actively participated in all SIOPEL trials and was appointed International Chair for SIOPEL 6. She was secretary of SIOPEN for 4 years, President from 2011-13 and currently remains on the Advisory Board. She retired from medical clinical practice in 2014 but continues to pursue the prevention of cisplatin ototoxicity through her consultancy with Fennec Pharmaceuticals. She has recently become chair of the Public Advisory Group for the Children’s Liver Tumour European Research Network (ChiLTERN).
She returned to Leuven to set up the paediatric haematology/oncology unit there and became Professor of Paediatric Haematology and Oncology in 1994. In 1999 she was invited back to be consultant oncologist at GOSH where her focus became solid tumours, particularly hepatoblastoma and neuroblastoma.
She actively participated in all SIOPEL trials and was appointed International Chair for SIOPEL 6. She was secretary of SIOPEN for 4 years, President from 2011-13 and currently remains on the Advisory Board. She retired from medical clinical practice in 2014 but continues to pursue the prevention of cisplatin ototoxicity through her consultancy with Fennec Pharmaceuticals. She has recently become chair of the Public Advisory Group for the Children’s Liver Tumour European Research Network (ChiLTERN).
2020 Trainee Award
Stephanie Rouse, BA
Boston Children's Hospital
"The Role of Sex in the Pathophysiology and Treatment of Cochlear Synaptopathy"
Boston Children's Hospital
"The Role of Sex in the Pathophysiology and Treatment of Cochlear Synaptopathy"
Morning Podium Presentations
Kumar Alagramam, PhD
Case Western Reserve University "Strategic modeling of hereditary hair cell dysfunction for efficacy evaluation" |
|
Alec Salt, PhD
Washington University School of Medicine "Drug therapy of the inner ear: technical considerations relevant to systemic, intratympanic and direct perilymphatic deliveries" |
Thanos Tzounopoulos, PhD
University of Pittsburgh "Cellular and molecular mechanisms driving drug discovery and development for tinnitus" |
Afternoon Corporate Speakers
Jonathan Kil, MD
CEO and CMO Sound Pharmaceuticals "Development of SPI-1005, the first oral drug for the prevention and treatment of hearing loss and tinnitus" Ning Pan, PhD
Associate Director of Pharmacology Decibel Therapeutics "Dual-AAV delivery of otoferlin durably rescues hearing in congenitally deaf preclinical models" |
Will McLean, PhD
Co-Founder VP, Biology and Regenerative Medicine Frequency Therapeutics "FX-322, a potential small molecule combination therapy for sensorineural hearing loss" Fabrice Piu, PhD
VP, Research and Preclinical Development Otonomy Therapeutics "Targeted delivery of drugs to the Inner ear compartment" |
Sponsored by the Bellucci DePaoli Family Foundation. Alumnus Dr. Richard J. Bellucci, MD '42 was a national leader in the utilization of ear surgical techniques to treat conductive hearing loss. Questions? Email [email protected]. |
Hybrid One-Day Event
May 17, 2024 Free Attendance |